Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 1 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
UNIVERSIDAD DE SEVILLA is currently managing 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. The 5 actions are concentrated within 1 distinct art unit, which indicates a specific technical focus for the university's current patent applications. This concentration in 1 art unit allows the university to develop a prosecution strategy that aligns with the specific examination standards of that division.
The workload is distributed among 4 distinct examiners. Because there are 4 distinct examiners for the 5 pending office actions, some examiners handle multiple cases. This distribution provides some diversification in the prosecution experience while still maintaining a relatively small pool of USPTO contacts.
CHO, DAVID H is the busiest examiner for the university, with 2 pending office actions currently under review. Since the busiest examiner handles 2 of the 5 pending office actions, his individual review process has a significant impact on the university's portfolio. This concentration requires the university to pay close attention to the specific preferences of CHO, DAVID H to ensure the success of these active cases.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHO, DAVID H | 2 | 31.9% | +67.0% |
| GARNER, LILY CRABTREE | 1 | 68.2% | +16.2% |
| HAWKINS, AMANDA SALATA | 1 | 12.0% | +45.2% |
| DACE DENITO, ALEXANDRA GERALDINE | 1 | 56.3% | +40.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19055973 | ULTRA-COMPACT HIGH-FIELD SPHERICAL TOKAMAK FOR FUSION ENERGY | GARNER, LILY CRABTREE | — |
| 18837024 | CAROTENOID-ENRICHED EXTRA VIRGIN OLIVE OIL, PROCESS FOR OBTAINING IT AND FUNCTIONAL FOODSTUFF COMPRISING IT | HAWKINS, AMANDA SALATA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17599463 | NANOSYSTEM BASED ON MICRORNA FOR TREATING OBESITY | DACE DENITO, ALEXANDRA GERALDINE | 8d |
| 19055973 | ULTRA-COMPACT HIGH-FIELD SPHERICAL TOKAMAK FOR FUSION ENERGY | GARNER, LILY CRABTREE | — |
| 18837024 | CAROTENOID-ENRICHED EXTRA VIRGIN OLIVE OIL, PROCESS FOR OBTAINING IT AND FUNCTIONAL FOODSTUFF COMPRISING IT | HAWKINS, AMANDA SALATA | — |
| 18702863 | OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | CHO, DAVID H | — |
| 18702858 | OLIGOSACCHARIDE COMPLEXES AND USES | CHO, DAVID H | — |
| Art Unit | Apps |
|---|---|
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19055973 | ULTRA-COMPACT HIGH-FIELD SPHERICAL TOKAMAK FOR FUSION ENERGY | GARNER, LILY CRABTREE | — | §101§102§103§112 | Non-Final OA | — | Pending | Feb 18, 2025 |
| 18837024 | CAROTENOID-ENRICHED EXTRA VIRGIN OLIVE OIL, PROCESS FOR OBTAINING IT AND FUNCTIONAL FOODSTUFF COMPRISING IT | HAWKINS, AMANDA SALATA | — | §103 | Non-Final OA | — | Pending | Aug 08, 2024 |
| 18702863 | OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | CHO, DAVID H | — | §112DP | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18702858 | OLIGOSACCHARIDE COMPLEXES AND USES | CHO, DAVID H | — | §103§112DP | Non-Final OA | — | Pending | Apr 19, 2024 |
| 17599463 | NANOSYSTEM BASED ON MICRORNA FOR TREATING OBESITY | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §112 | Final Rejection | 8d | Pending | Sep 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial